Mikael Knip

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Vactech Oy, Vactech 0Y, Other. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikael Knip. Retrieved from https://idiyas.com/inventor/mikael-knip

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 75.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Tampere, FI (2006 - 2011)
Helsinki, FI (2012 - 2024)

Company Filing History:

2 out of 834,570

Other

patents

Years Active: 2006-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11911456 - Multi-CBV vaccine for preventing or treating type I diabetes (2024-02-27),

2. 11633468 - Multi-CBV vaccine for preventing or treating type 1 diabetes (2023-04-25),

3. 10780157 - Multi-CBV vaccine for preventing or treating type I diabetes (2020-09-22),

4. 10675344 - Multi-CBV vaccine for preventing or treating type I diabetes (2020-06-09),

5. 10258685 - Multi-CBV vaccine for preventing or treating type I diabetes (2019-04-16),

6. 8182805 - Prevention of allergic sensitization (2012-05-22),

7. 7972592 - Prevention of type 1 diabetes and other non-polio enterovirus diseases (2011-07-05),

8. 7090855 - Prevention of Type 1 diabetes and other non-polio enterovirus diseases (2006-08-15),

Title: The Innovative Contributions of Mikael Knip

Introduction

Mikael Knip is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the field of medical research, particularly in the development of vaccines. With a total of eight patents to his name, Knip's work focuses on innovative solutions for preventing and treating diseases.

Latest Patents

One of Mikael Knip's latest patents is a Multi-CBV vaccine designed for preventing or treating type 1 diabetes. This invention comprises coxsackie B virus strains CBV1 and CBV2, along with at least one additional strain selected from CBV3, CBV4, CBV5, and CBV6. The vaccine contains these viruses in an inactivated form, as components of the virus, or as antibodies against the virus. This innovative vaccine has shown effectiveness in both preventing and treating type 1 diabetes, marking a significant advancement in medical science.

Career Highlights

Throughout his career, Mikael Knip has worked with various organizations, including Vactech Oy. His experience in the field has allowed him to develop groundbreaking inventions that contribute to public health and medical advancements.

Collaborations

Mikael has collaborated with notable colleagues such as Olli Laitinen and Outi Tolonen. These partnerships have played a crucial role in the development of his innovative projects.

Conclusion

Mikael Knip's contributions to the field of vaccine development, particularly his work on the Multi-CBV vaccine, highlight his role as a leading inventor in medical research. His dedication to innovation continues to pave the way for advancements in the prevention and treatment of diseases.

Profile summary based on public USPTO records.